ChemicalBook > CAS DataBase List > NMS-P715

NMS-P715

Product Name
NMS-P715
CAS No.
1202055-34-2
Chemical Name
NMS-P715
Synonyms
CS-1822;NMS-P715;NMS P715 analog;NMS-P715 analog;NMS-P 715 analog;NMS P715 ANALOG;NMS-P 715 ANALOG;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, N-(2,6-diethylphenyl)-4,5-dihydro-8-[[2-methoxy-4-[[(1-methyl-4-piperidinyl)amino]carbonyl]phenyl]amino]-1-methyl-;N-(2,6-diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-yl)carbaMoyl]-2-(trifluoroMethoxy)phenyl}aMino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxaMide;N-(2,6-diethylphenyl)-1-methyl-8-((4-((1-methylpiperidin-4-yl)carbamoyl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide NMS-P715
CBNumber
CB22628196
Molecular Formula
C35H42N8O3
Formula Weight
622.76
MOL File
1202055-34-2.mol
More
Less

NMS-P715 Property

Density 
1.32±0.1 g/cm3(Predicted)
storage temp. 
-70°C
solubility 
Soluble in DMSO
form 
Powder
pka
11.75±0.70(Predicted)
More
Less

Safety

WGK Germany 
WGK 1
Storage Class
10 - Combustible liquids
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
API0014037
Product name
NMS-P715
Purity
95.00%
Packaging
5MG
Price
$358.6
Updated
2021/12/16
Crysdot
Product number
CD31004311
Product name
NMS-P715analog
Purity
98+%
Packaging
5mg
Price
$111
Updated
2021/12/16
More
Less

NMS-P715 Chemical Properties,Usage,Production

Uses

An orally bioavailable, ATP-competitive, pyrazolo-quinazoline, MPS1 inhibitor (IC50 = 182 nM, Ki = 0.99 nM) that is shown to act in a reversible and time-dependent manner. It demonstrates selectivity for MPS1 against a panel of 60 kinases, displaying activity against only three kinases, CK2, MELK, and NEK6 (<10 µM), but not against other mitotic kinases including PLK1, CDK1, Aurora A, Aurora B, or the SAC kinase BUB1, in an in vitro kinase assay. It promotes massive SAC (spindle assembly checkpoint) override (EC50 = 65 nM) in nocodazole-arrested U20S cells and elicits a reduction in the G1 and G2/M phase of the cell cycle in A2780 ovarian cancer cells, similar to RNAi-mediated MPS1 silencing. In addition, it is shown to inactivate SAC, delocalize kinetochore components, and inhibit the proliferation of select cancer cell lines (IC50 ~ 1 µM), without marked activity among a panel of 127 normal cell lines. Also, it inhibits A2780 tumor xenograft growth in mice (90 mg/kg/day, o.s., in vivo) by 53% without marked body weight loss.

Biological Activity

Cell permeable: yes', 'Primary Target
MPS1', 'Reversible: yes

NMS-P715 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NMS-P715 Suppliers

LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4827
Advantage
55
AN PharmaTech Co Ltd
Tel
86(21)68097365
Fax
86(21)33321566
Email
sales@anpharma.net
Country
China
ProdList
4891
Advantage
55
Struchem Co., Ltd.
Tel
0512-63009836 18994340901
Fax
0512-63006936
Email
helen@struchem.com
Country
China
ProdList
3979
Advantage
60
Medi-tech Bioscientific Co., Ltd.
Tel
0519-83246372 13585352506
Fax
0519-83246372
Country
China
ProdList
1844
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30227
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
Beijing xinyanhui pharmaceutical research and development co., LTD
Tel
13969155946
Email
1461866103@qq.com
Country
China
ProdList
16111
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-57896695 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9779
Advantage
58

1202055-34-2, NMS-P715Related Search:


  • NMS-P715
  • N-(2,6-diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-yl)carbaMoyl]-2-(trifluoroMethoxy)phenyl}aMino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxaMide
  • NMS P715 analog
  • NMS-P 715 analog
  • NMS-P715 analog
  • N-(2,6-diethylphenyl)-1-methyl-8-((4-((1-methylpiperidin-4-yl)carbamoyl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide NMS-P715
  • CS-1822
  • NMS P715 ANALOG;NMS-P 715 ANALOG
  • 1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, N-(2,6-diethylphenyl)-4,5-dihydro-8-[[2-methoxy-4-[[(1-methyl-4-piperidinyl)amino]carbonyl]phenyl]amino]-1-methyl-
  • 1202055-34-2
  • C35H42N8O3